Challenges and Strategies in Managing β-Lactam–Resistant Pseudomonas aeruginosa in China
The Journal of Infectious Diseases · 2026
DOI: 10.1093/infdis/jiag033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Yue Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Pseudomonas Infections, beta-Lactam Resistance, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 107 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
β-Lactam antibiotics are the cornerstone of therapy for Pseudomonas aeruginosa infections. Their effectiveness, however, has been increasingly compromised by antimicrobial resistance. This article presents a perspective on the evolving challenges and strategies associated with β-lactam resistance in P. aeruginosa, with a particular focus on China. The perspective was developed through a focused narrative review of recent clinical, epidemiological, and mechanistic studies. We first outline the current epidemiology of β-lactam–resistant P. aeruginosa, highlighting regional trends and the dissemination of high-risk clones. We then review the evolving β-lactam resistance mechanisms, emphasizing the prevalence and variety of carbapenemases. Finally, we discuss therapeutic strategies for managing resistant infections. This includes diagnostic advances, rational selection of novel β-lactam agents, dosing optimization, and combination regimens. Together, these insights provide a structured framework for understanding and managing β-lactam–resistant P. aeruginosa in contemporary clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou, China.
- Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
ORCID-Profile: Xiaoting Hua, Yunsong Yu
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Li, Y., Cai, H., Hua, X., & Yu, Y. (2026). Challenges and Strategies in Managing β-Lactam–Resistant Pseudomonas aeruginosa in China. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag033
Vancouver
Li Y, Cai H, Hua X, Yu Y. Challenges and Strategies in Managing β-Lactam–Resistant Pseudomonas aeruginosa in China. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag033
BibTeX
@article{Li2026,
author = {Li, Yue and Cai, Heng and Hua, Xiaoting and Yu, Yunsong},
title = {Challenges and Strategies in Managing β-Lactam–Resistant Pseudomonas aeruginosa in China},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiag033}
}
EUVIMED